• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有疫苗诱导抗原结合热点的抗体谱系可产生广泛的 HIV 中和作用。

Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization.

机构信息

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA.

Zuckerman Mind Brain Behavior Institute, Columbia University, New York, NY 10027, USA.

出版信息

Cell. 2019 Jul 25;178(3):567-584.e19. doi: 10.1016/j.cell.2019.06.030.

DOI:10.1016/j.cell.2019.06.030
PMID:31348886
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6755680/
Abstract

The vaccine-mediated elicitation of antibodies (Abs) capable of neutralizing diverse HIV-1 strains has been a long-standing goal. To understand how broadly neutralizing antibodies (bNAbs) can be elicited, we identified, characterized, and tracked five neutralizing Ab lineages targeting the HIV-1-fusion peptide (FP) in vaccinated macaques over time. Genetic and structural analyses revealed two of these lineages to belong to a reproducible class capable of neutralizing up to 59% of 208 diverse viral strains. B cell analysis indicated each of the five lineages to have been initiated and expanded by FP-carrier priming, with envelope (Env)-trimer boosts inducing cross-reactive neutralization. These Abs had binding-energy hotspots focused on FP, whereas several FP-directed Abs induced by immunization with Env trimer-only were less FP-focused and less broadly neutralizing. Priming with a conserved subregion, such as FP, can thus induce Abs with binding-energy hotspots coincident with the target subregion and capable of broad neutralization.

摘要

诱导能够中和多种 HIV-1 毒株的抗体(Abs)一直是一个长期目标。为了了解如何能够诱导出广泛中和抗体(bNAbs),我们在接种疫苗的猕猴中鉴定、表征和跟踪了针对 HIV-1-融合肽(FP)的五个中和 Ab 谱系,随着时间的推移。遗传和结构分析表明,这两个谱系中的两个属于可重复的类别,能够中和多达 59%的 208 种不同的病毒株。B 细胞分析表明,这五个谱系中的每一个都通过 FP 载体引发和扩增,包膜(Env)三聚体增强诱导交叉反应性中和。这些 Ab 的结合能热点集中在 FP 上,而免疫接种仅用 Env 三聚体诱导的几个 FP 定向 Ab 则不那么集中在 FP 上,也不那么广泛中和。因此,用保守的亚区域(如 FP)进行引发,可以诱导出与目标亚区域具有相同结合能热点的 Ab,并且能够进行广泛中和。

相似文献

1
Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization.具有疫苗诱导抗原结合热点的抗体谱系可产生广泛的 HIV 中和作用。
Cell. 2019 Jul 25;178(3):567-584.e19. doi: 10.1016/j.cell.2019.06.030.
2
Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses.开发一种 3Mut-Apex-Stabilized 包膜三聚体,当用于增强融合肽指导的疫苗诱导的反应时,可扩大 HIV-1 中和广度。
J Virol. 2020 Jun 16;94(13). doi: 10.1128/JVI.00074-20.
3
Consistent elicitation of cross-clade HIV-neutralizing responses achieved in guinea pigs after fusion peptide priming by repetitive envelope trimer boosting.经融合肽引发后,通过重复的包膜三聚体加强,豚鼠体内产生了跨型 HIV 中和反应。
PLoS One. 2019 Apr 17;14(4):e0215163. doi: 10.1371/journal.pone.0215163. eCollection 2019.
4
Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell Signature.免疫监测揭示融合肽引发具有特征性早期 B 细胞特征的跨 HIV 中和反应的印迹。
Cell Rep. 2020 Aug 4;32(5):107981. doi: 10.1016/j.celrep.2020.107981.
5
HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates.非人灵长类动物免疫接种引发的HIV-1交叉反应性原发性病毒中和抗体反应
J Virol. 2017 Oct 13;91(21). doi: 10.1128/JVI.00910-17. Print 2017 Nov 1.
6
Antibodies from Rabbits Immunized with HIV-1 Clade B SOSIP Trimers Can Neutralize Multiple Clade B Viruses by Destabilizing the Envelope Glycoprotein.用 HIV-1 分 B 亚型 SOSIP 三聚体免疫的兔子产生的抗体可以通过破坏包膜糖蛋白来中和多种 B 亚型病毒。
J Virol. 2021 Aug 10;95(17):e0009421. doi: 10.1128/JVI.00094-21.
7
Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1.基于表位的疫苗设计产生了靶向融合肽的抗体,这些抗体能够中和多种 HIV-1 毒株。
Nat Med. 2018 Jun;24(6):857-867. doi: 10.1038/s41591-018-0042-6. Epub 2018 Jun 4.
8
Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability.糖基化修饰的 HIV NFL 包膜三聚体脂质体疫苗诱导针对多个弱点的广谱中和抗体。
Immunity. 2019 Nov 19;51(5):915-929.e7. doi: 10.1016/j.immuni.2019.10.008. Epub 2019 Nov 12.
9
Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses.基于具有早期广泛中和反应的患者的 HIV-1 包膜的病毒样颗粒免疫原可有效诱导包膜特异性抗体应答。
J Virol. 2022 Jan 12;96(1):e0134321. doi: 10.1128/JVI.01343-21. Epub 2021 Oct 20.
10
Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.多种重组HIV-1包膜蛋白无法激活表达广泛中和抗HIV-1抗体PG9和447-52D的种系B细胞受体的B细胞。
J Virol. 2014 Mar;88(5):2645-57. doi: 10.1128/JVI.03228-13. Epub 2013 Dec 18.

引用本文的文献

1
The N terminus of H3-influenza hemagglutinin as a site-of-vulnerability to neutralizing antibody.甲型流感血凝素的N端作为中和抗体的敏感位点。
Structure. 2025 Aug 14. doi: 10.1016/j.str.2025.07.015.
2
Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopes.用于引发靶向多个表位的抗体的HIV-1候选疫苗的设计与特性分析
J Exp Med. 2025 Oct 6;222(10). doi: 10.1084/jem.20250693. Epub 2025 Aug 12.
3
The HIV-1 envelope glycoprotein: structure, function and interactions with neutralizing antibodies.人类免疫缺陷病毒1型包膜糖蛋白:结构、功能及与中和抗体的相互作用
Nat Rev Microbiol. 2025 Jul 23. doi: 10.1038/s41579-025-01206-6.
4
improvement of affinity for highly protective anti-malarial antibodies.提高对高度保护性抗疟疾抗体的亲和力。
iScience. 2025 Jun 14;28(7):112903. doi: 10.1016/j.isci.2025.112903. eCollection 2025 Jul 18.
5
Optimizing human B cell repertoire analyses to interpret clinical data and design sequential HIV vaccines.优化人类B细胞库分析以解读临床数据并设计序贯HIV疫苗。
NPJ Vaccines. 2025 Jul 17;10(1):157. doi: 10.1038/s41541-025-01168-z.
6
Transient glycan shield reduction induces CD4-binding site broadly neutralizing antibodies in SHIV-infected macaques.短暂的聚糖屏蔽减少在感染SHIV的猕猴中诱导出结合CD4位点的广谱中和抗体。
Cell Rep. 2025 Jun 24;44(6):115848. doi: 10.1016/j.celrep.2025.115848. Epub 2025 Jun 13.
7
Conformational trajectory of the HIV-1 fusion peptide during CD4-induced envelope opening.HIV-1融合肽在CD4诱导包膜开放过程中的构象轨迹。
Nat Commun. 2025 May 17;16(1):4595. doi: 10.1038/s41467-025-59721-2.
8
Vaccination of nonhuman primates elicits a broadly neutralizing antibody lineage targeting a quaternary epitope on the HIV-1 Env trimer.对非人类灵长类动物进行疫苗接种可引发一种广泛中和抗体谱系,该谱系靶向HIV-1包膜三聚体上的一个四级表位。
Immunity. 2025 Jun 10;58(6):1598-1613.e8. doi: 10.1016/j.immuni.2025.04.010. Epub 2025 May 7.
9
Inclusion of a retroviral protease enhances the immunogenicity of VLP-forming mRNA vaccines against HIV-1 or SARS-CoV-2 in mice.包含逆转录病毒蛋白酶可增强针对HIV-1或SARS-CoV-2的形成病毒样颗粒的mRNA疫苗在小鼠中的免疫原性。
Sci Transl Med. 2025 Apr 30;17(796):eadt9576. doi: 10.1126/scitranslmed.adt9576.
10
Self-assembled epitope-based nanoparticles targeting the SARS-CoV-2 spike protein enhanced the immune response and induced potential broad neutralizing activity.靶向严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的基于表位的自组装纳米颗粒增强了免疫反应并诱导了潜在的广泛中和活性。
Front Cell Infect Microbiol. 2025 Apr 9;15:1560330. doi: 10.3389/fcimb.2025.1560330. eCollection 2025.

本文引用的文献

1
Consistent elicitation of cross-clade HIV-neutralizing responses achieved in guinea pigs after fusion peptide priming by repetitive envelope trimer boosting.经融合肽引发后,通过重复的包膜三聚体加强,豚鼠体内产生了跨型 HIV 中和反应。
PLoS One. 2019 Apr 17;14(4):e0215163. doi: 10.1371/journal.pone.0215163. eCollection 2019.
2
An Antigenic Atlas of HIV-1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes.HIV-1 逃避广泛中和抗体的抗原图谱区分功能和结构表位。
Immunity. 2019 Feb 19;50(2):520-532.e3. doi: 10.1016/j.immuni.2018.12.017. Epub 2019 Jan 29.
3
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design.HIV-1 中和抗体特征及其在表位靶向疫苗设计中的应用。
Cell Host Microbe. 2019 Jan 9;25(1):59-72.e8. doi: 10.1016/j.chom.2018.12.001.
4
Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers.疫苗诱导的非人类灵长类动物同源二级 SHIV 挑战的保护依赖于血清中和抗体滴度。
Immunity. 2019 Jan 15;50(1):241-252.e6. doi: 10.1016/j.immuni.2018.11.011. Epub 2018 Dec 11.
5
Structural Survey of Broadly Neutralizing Antibodies Targeting the HIV-1 Env Trimer Delineates Epitope Categories and Characteristics of Recognition.广泛中和抗体靶向 HIV-1 Env 三聚体的结构调查,描绘了表位类别和识别特征。
Structure. 2019 Jan 2;27(1):196-206.e6. doi: 10.1016/j.str.2018.10.007. Epub 2018 Nov 21.
6
Recent progress in broadly neutralizing antibodies to HIV.HIV 广谱中和抗体的最新进展。
Nat Immunol. 2018 Nov;19(11):1179-1188. doi: 10.1038/s41590-018-0235-7. Epub 2018 Oct 17.
7
Complete functional mapping of infection- and vaccine-elicited antibodies against the fusion peptide of HIV.全面分析针对 HIV 融合肽的感染和疫苗诱导抗体的功能。
PLoS Pathog. 2018 Jul 5;14(7):e1007159. doi: 10.1371/journal.ppat.1007159. eCollection 2018 Jul.
8
Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1.基于表位的疫苗设计产生了靶向融合肽的抗体,这些抗体能够中和多种 HIV-1 毒株。
Nat Med. 2018 Jun;24(6):857-867. doi: 10.1038/s41591-018-0042-6. Epub 2018 Jun 4.
9
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure.基于抗体鉴定、B 细胞发生和表位结构的 HIV-1 疫苗。
Immunity. 2018 May 15;48(5):855-871. doi: 10.1016/j.immuni.2018.04.029.
10
Mapping mutational effects along the evolutionary landscape of HIV envelope.绘制 HIV 包膜在进化景观中的突变效应图谱。
Elife. 2018 Mar 28;7:e34420. doi: 10.7554/eLife.34420.